ArticleJournal of the Pediatric Infectious Diseases Society2021

Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study.

Jesse Papenburg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.